JCAR017
JCAR017-BCM-001
Phase 2 small_molecule completed
Quick answer
JCAR017 for Lymphoma, Non-Hodgkin is a Phase 2 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Lymphoma, Non-Hodgkin
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed